Scott Tagawa

Scott Tagawa

Company: Weill Cornell University

Job title: Professor

Seminars:

Using Combination Based Approaches to Address Target Heterogeneity, Radio-Resistance & Synergism With Additional Therapeutic Modalities 9:30 am

Describing principles of combination therapy for radionuclide therapies Providing methods of improving therapeutic index Presenting prospective data with combination therapy (TRT + other modalities and TRT + TRT)Read more

day: Conference Day Two

Maximizing Combination Approaches to Transform Safety & Efficacy Profiles 11:00 am

Garnering excitement across the precision oncology field, combination-based approaches have proven to expand therapeutic efficacy and optimize treatment outcomes. It is no surprise that the radiopharmaceuticals space is following full steam ahead, as we see early clinical data and uncover more about the preclinical learnings in dual therapies. Discover more on combinations: Explore immune checkpoint…Read more

day: Workshop B

Addressing the Silos to Move Toward an Integrated Approach With Enhanced Trial Design & Execution Across Radiopharmaceutical Research 8:30 am

Radiopharmaceutical development is driven by collaboration between radio pharmacists, nuclear medicine specialists, chemists, bioengineers and more. While the industry is on the brink of expanding their horizons to even more unmet medical needs, there is a clear bottleneck in the blend of expertise required to design and run a radiopharmaceutical trial. Learn perspectives from key…Read more

day: Workshop D

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.